AravindhanVeerapandiyanMD

Clinical Trials

• Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy Start of enrollment: 2021 Mar 03

  Completed

  Phase 2, Phase 3

• A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice Start of enrollment: 2021 Apr 22

  Recruiting

• CureDuchenne Link®: A Resource for Research Start of enrollment: 2021 Jul 09

  Recruiting

  Roles: Contact

• A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2023 May 31

  Recruiting

  Phase 3

  Roles: Principal Investigator

• An Observational Study Comparing Delandistrogene Moxeparvovec With Standard of Care in Participants With Duchenne Muscular Dystrophy Start of enrollment: 2024 Feb 07

  Recruiting

• AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2023 Jan 04

  Recruiting

  Phase 1, Phase 2

• Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) Start of enrollment: 2023 May 31

  Recruiting

  Phase 3

• A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy Start of enrollment: 2022 Jun 22

  Recruiting

  Phase 3

• Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy Start of enrollment: 2021 Aug 23

  Recruiting

  Phase 2, Phase 3

• Join now to see all